Connect with us
Mon – Sat 09:00 – 06:00
Call Us 82838 57755
Glimepiride and Metformin Hydrochloride (SR) Tablets IP
PRODUCT NAME : GLIFAB-M1
Dosage Form: Tablet
Packing: 10×10 Blister
GLIFAB-M1 Tablet is a combination of two anti-diabetic medicines: Glimepiride 1 mg and Metformin 500 mg (SR). It is used to manage type 2 diabetes mellitus in adults. This medicine helps control blood sugar levels by improving insulin sensitivity and reducing glucose production in the liver, especially when lifestyle changes like diet and exercise are not enough.
- Real Time 0 Visitors Right Now
MORE DETAILS ABOUT GLIFAB-M1
Glimepiride 1mg/2mg + Metformin HCl 500mg
Glimepiride :
- Has dual molecules of action, by stimulating insulin production and increases activity of peripheral insulin intramuscular receptor
An diabetic that :
- Causes a progressive decrease of fasting blood glucose
Metformin HCl
Displays contra pancreatic effects
Decreases hepatic glucose production
Type II diabetes
Diet and exercise uncontrolled diabetes
Also Available
Indications
GLIFAB-MP1 / MP2
Glimepiride 1mg/2mg + Metformin 500mg + Pioglitazone 7.5mg
VYOFAB MP1/MP2
Metformin Hydrochloride 500 mg , Prolonged Release and Glimepiride 1 mg, Voglibose 0.1/ 0.2 mg Tablets
AMLOFAB-50 AT / 50
Amlodipine Besylate IP 5 mg + Atenolol 50mg/
GLIFAB-MP1 / MP2
Glimepiride 1mg/2mg + Metformin 500mg + Pioglitazone 7.5mg
VYOFAB-0.2/0.3
Voglibose 0.2/0.3
TELFAB-40
Telmisartan 40mg
- Improvement of postprandial hyperglycemia In diabetes mellitus when sufficient effect has not been obtained
- The combination provides additional glycemic control
Always Trust the Superior BIOMORPH Lifesciences Pvt. Ltd.
